1. Home
  2. VATE vs CSBR Comparison

VATE vs CSBR Comparison

Compare VATE & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo INNOVATE Corp.

VATE

INNOVATE Corp.

N/A

Current Price

$5.37

Market Cap

75.2M

Sector

Industrials

ML Signal

N/A

Logo Champions Oncology Inc.

CSBR

Champions Oncology Inc.

N/A

Current Price

$4.81

Market Cap

65.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VATE
CSBR
Founded
1994
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
75.2M
65.4M
IPO Year
1996
2015

Fundamental Metrics

Financial Performance
Metric
VATE
CSBR
Price
$5.37
$4.81
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 54.4K
8.2K
Earning Date
11-16-2026
12-14-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
★ $1,246,000,000.00
$2,900,000.00
Revenue This Year
N/A
$9.83
Revenue Next Year
N/A
$8.50
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 12.55
N/A
52 Week Low
$3.75
$4.59
52 Week High
$21.30
$8.31

Technical Indicators

Market Signals
Indicator
VATE
CSBR
Relative Strength Index (RSI) 29.69 48.67
Support Level $5.35 $4.71
Resistance Level $5.56 $5.17
Average True Range (ATR) 0.36 0.20
MACD -0.01 0.01
Stochastic Oscillator 4.02 42.31

Price Performance

Historical Comparison
VATE
CSBR

About VATE INNOVATE Corp.

Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments. Its segments include Infrastructure, Life Sciences and Spectrum, and Other segment. Through its subsidiaries it provides fully integrated structural and steel construction services; supports healthcare and biotechnology product development; and operates Over-The-Air (OTA) broadcasting stations across the United States (U.S.) including Puerto Rico.

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment which is oncology services. Its research center operates in both regulatory and non-regulatory environments and consists of a comprehensive set of computational and experimental research platforms. The company's pharmacology, biomarker, and data platforms are designed to facilitate drug discovery and development at lower costs and increased speeds. Its revenue is majorly derived from research services.

Share on Social Networks: